Biomarker-Concordant Steroid Administration in Severe Coronavirus Disease-2019.

Aysun TekinJuan P DomecqDiana J Valencia MoralesKrishna Mohan SurapeneniIgor B ZabolotskikhRodrigo Cartin-CebaPhilippe ClevenberghJean-Baptiste MeslandRolando Claure-Del GranadoOscar Y GavidiaVishakha K KumarRahul KashyapAllan J WalkeyOgnjen GajicYewande Odeyeminull null

Published in: Journal of intensive care medicine (2023)

Biomarker-concordant corticosteroid treatment was associated with lower odds of in-hospital mortality in severe COVID-19.

Keyphrases

coronavirus disease
early onset
sars cov
respiratory syndrome coronavirus
drug induced
combination therapy